We believe Genome Editing enables the biotech revolution - Akribion Genomics

Specialty Chemicals Article 30.01.24

Publication
An alternative CRISPR-Cas nuclease for biotech & pharma Specialty Chemicals has published an article on Akribion’s nuclease technology. Our colleagues Michael Krohn and Dirk Sombroek introduce its mode of action,…

PI BRAIN 14.9.23

Press Release
BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®

PI BRAIN 12.9.23

Press Release
BRAIN Biotech AG Scientist receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family